Literature DB >> 15605306

Obesity and the liver: developmental perspectives.

Alison G Hoppin1.   

Abstract

Obesity now affects 15% of children and adolescents in the United States. Many of the complications of obesity are seen in children, including fatty liver disease, gallstones, hyperlipidemia, insulin resistance, and type 2 diabetes. Infants and children also have unique susceptibilities to and manifestations of liver disease caused by total parenteral nutrition. In addition to genetic and environmental influences on obesity, there is increasing evidence supporting the idea of "metabolic programming," in which environmental influences at critical periods during development have permanent effects on an individual's predisposition to obesity and metabolic disease. Understanding the role the liver plays in the development and expression of the metabolic program will provide important insight into the pathogenesis and treatment of fatty liver disease, and of obesity itself.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15605306     DOI: 10.1055/s-2004-860867

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  8 in total

1.  Routine abdominal drains after laparoscopic sleeve gastrectomy: a retrospective review of 353 patients.

Authors:  Konstantinos Albanopoulos; Leonidas Alevizos; Dimitrios Linardoutsos; Evangelos Menenakos; Konstantinos Stamou; Konstantinos Vlachos; George Zografos; Emmanuel Leandros
Journal:  Obes Surg       Date:  2011-06       Impact factor: 4.129

2.  Celastrol Protects From Cholestatic Liver Injury Through Modulation of SIRT1-FXR Signaling.

Authors:  Qi Zhao; Fang Liu; Yan Cheng; Xue-Rong Xiao; Dan-Dan Hu; Ying-Mei Tang; Wei-Min Bao; Jin-Hui Yang; Tao Jiang; Jia-Peng Hu; Frank J Gonzalez; Fei Li
Journal:  Mol Cell Proteomics       Date:  2019-01-07       Impact factor: 5.911

3.  Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome.

Authors:  Samer G Mattar; Laura M Velcu; Mordechai Rabinovitz; A J Demetris; A M Krasinskas; Emma Barinas-Mitchell; George M Eid; Ramesh Ramanathan; Debra S Taylor; Philip R Schauer
Journal:  Ann Surg       Date:  2005-10       Impact factor: 12.969

4.  Incidental Gastrointestinal Stromal Tumors (GIST) During Laparoscopic Sleeve Gastrectomy Procedures: a Retrospective Study.

Authors:  Yusuf O Hallak; Osama Karajeh; Homero Rivas; Kevin Helling
Journal:  Obes Surg       Date:  2021-11-10       Impact factor: 4.129

5.  High complication rate after Swedish adjustable gastric banding in younger patients < or =25 years.

Authors:  Reinhard Mittermair; Franz Aigner; Sabine Obermüller
Journal:  Obes Surg       Date:  2008-11-08       Impact factor: 4.129

6.  Laparoscopic sleeve gastrectomy for morbid obesity.

Authors:  Antonio Iannelli; Raffaella Dainese; Thierry Piche; Enrico Facchiano; Jean Gugenheim
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

7.  Laparoscopic Sleeve Gastrectomy and Crural Repair as a Treatment of Morbid Obesity Associated with Gastroesophageal Reflux.

Authors:  Sameh Gabr Attia
Journal:  Electron Physician       Date:  2017-01-25

8.  Association between obese phenotypes and risk of carotid artery plaque among chinese male railway drivers.

Authors:  Jia Pan; Zihang Wang; Chaohui Dong; Bo Yang; Lei Tang; Peng Jia; Shujuan Yang; Honglian Zeng
Journal:  BMC Public Health       Date:  2022-10-05       Impact factor: 4.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.